![Stuart Naylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Naylor
Corporate Officer/Principal presso
MEIRAGTX HOLDINGS PLC
Patrimonio netto: 8 M $ in data 31/07/2026
Profilo
Stuart Naylor is Chief Development Officer at MeiraGTx Holdings Plc since 2019.
Formerly, Dr. Naylor was Chief Executive Officer at MeiraGTx UK II Ltd. from 2015 to 2016, Managing Director at Coltivare Ltd. from 2013 to 2015, and Chief Scientific Officer & Executive Director at Oxford Biomedica Plc from 2010 to 2013.
Education includes undergraduate studies at the University of Warwick and graduate studies at King's College London.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/07/2026 | 640.846 ( 0,69% ) | 8 M $ | 31/07/2026 |
Posizioni attive di Stuart Naylor
| Società | Posizione | Inizio |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Corporate Officer/Principal | 01/04/2015 |
Precedenti posizioni note di Stuart Naylor
| Società | Posizione | Fine |
|---|---|---|
MeiraGTx UK II Ltd.
 MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Amministratore Delegato | 01/04/2016 |
Coltivare Ltd.
 Coltivare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Amministratore Delegato | 01/04/2015 |
| OXFORD BIOMEDICA PLC | Direttore Tecnico/Scientifico/R&S | 06/06/2013 |
Formazione di Stuart Naylor
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
35
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Holdings Plc
 MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
MeiraGTx UK II Ltd.
MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Health Technology |
Coltivare Ltd.
Coltivare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
